This topic contains a solution. Click here to go to the answer

Author Question: Chamberlin (1990) compared 13- to 18-year-olds in Oregon Treatment Foster Care (OTFC) to those ... (Read 38 times)

neverstopbelieb

  • Hero Member
  • *****
  • Posts: 534
Chamberlin (1990) compared 13- to 18-year-olds in Oregon Treatment Foster Care (OTFC) to those teenagers treated in community residential treatment. Over a two year follow-up period, those in the OTFC group were found to be
 
  A. less likely to be incarcerated and more likely to complete treatment.
  B. more likely to be incarcerated and less likely to complete treatment.
  C. less likely to be incarcerated and less likely to complete treatment.
  D. more likely to be incarcerated and more likely to complete treatment.

Question 2

Oregon Treatment Foster Care has been identified as a model treatment program by the
 
  A. U.S. Attorney General.
  B. U.S. Surgeon General.
  C. U.S. Department of Health.
  D. U.S. Commission on Mental Health Policy and Initiatives.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sierramartinez

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

A

Answer to Question 2

B




neverstopbelieb

  • Member
  • Posts: 534
Reply 2 on: Jun 22, 2018
:D TYSM


mammy1697

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

For a complete list of videos, visit our video library